logo

Procter & Gamble Health Ltd. Financials

09:59 Jun 19

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5935.00
-16.00 (-0.27%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Procter & Gamble Health Ltd. Financials

Procter & Gamble Health Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5935.00
-16.00 (-0.27%)
09:59 Jun 19
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

9

Weakness

1

Opportunity

0

Threats

1

43.65 %

ROE %

29.51 %

ROA %

151.32

EPS

323.47

BVPS

0.00 %

Net Profit Margin

Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025
Net Sales
1008.73 1114.41 1229.62 1151.26 934.17
Operating Expenses +
762.71 846.73 904.94 845.26 615.78
Raw Material
310.28 344.55 358.99 329.69 247.75
Increase Decrease in Cost
4.54 -4.75 2.85 0.87 14.75
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
150.47 167.56 206.17 215.16 142.06
Miscellaneous Expenses
339.74 381.03 416.45 378.46 305.54
Operating Profit
246.02 267.68 324.68 306 318.39
Other Income
18.1 13.19 18.39 15.63 10.35
Depreciation
30.04 27.08 28.1 27.4 16.69
Interest
0.8 0.42 0.77 0.72 0.43
Profit before tax and exceptio..
233.28 253.37 314.2 293.51 311.62
Exceptional Items
0 0 0 -20.19 0
PBT
233.28 253.37 314.2 273.32 311.62
Provision for Taxation
56.48 60.85 84.73 72.34 77.21
Net Profit
176.8 192.52 229.47 200.98 234.41
NET Profit after MI
0 0 0 0 0
EPS
107 116 138 133 141.22
Operating Profit Margin (%)
24.39 24.02 26.4 26.58 34.08
Net Profit Margin (%)
17.53 17.28 18.66 17.46 25.09

Procter & Gamble Health Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 51.80 51.80 51.80 51.80 51.80
FII 6.90 7.00 6.60 6.40 6.20
MF 10.50 10.60 10.40 10.20 9.90
Others 3.70 4.10 4.40 4.40 3.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: